Akums Drugs & Pharmaceuticals Return on Equity (ROE) History

Akums Drugs & Pharmaceuticals Ltd Return on Equity

The Akums Drugs & Pharmaceuticals Ltd Return on Equity is a key financial metric used by investors to evaluate Akums Drugs & Pharmaceuticals Ltd's valuation, profitability, and overall financial performance. Tracking the Akums Drugs & Pharmaceuticals Ltd Return on Equity helps investors understand whether the stock is undervalued, fairly valued, or trading at a premium compared to its historical performance and industry peers.

Akums Drugs & Pharmaceuticals Ltd (NSE: AKUMS, BSE: 544222) is currently trading at ₹527.90, with a market capitalization of ₹85.14B. As a leading company in the Health technology sector and Biotechnology industry, monitoring the Akums Drugs & Pharmaceuticals Ltd Return on Equity is essential for fundamental analysis.

Akums Drugs & Pharmaceuticals Ltd Return on Equity Current Value

The current Akums Drugs & Pharmaceuticals Ltd Return on Equity stands at 18.

The latest Akums Drugs & Pharmaceuticals Ltd Return on Equity has increased compared to the previous period, indicating rising valuation or improved investor sentiment.

Akums Drugs & Pharmaceuticals Ltd Return on Equity Historical Trend

The Akums Drugs & Pharmaceuticals Ltd Return on Equity has shown the following historical trend:

• 2024: 18
• 2023: -0.57
• 2022: 14.17
• 2021: -33.52
• 2020: 0

The recent rise in Akums Drugs & Pharmaceuticals Ltd Return on Equity suggests strengthening valuation trends and improving market sentiment.

What Akums Drugs & Pharmaceuticals Ltd Return on Equity Indicates for Investors

The Akums Drugs & Pharmaceuticals Ltd Return on Equity plays a crucial role in understanding the company's financial health and valuation.

ROE indicates how efficiently the company generates returns for shareholders.

Akums Drugs & Pharmaceuticals Ltd Return on Equity Analysis Summary

The Akums Drugs & Pharmaceuticals Ltd Return on Equity remains a crucial metric for evaluating the company's valuation and financial stability. Investors tracking Akums Drugs & Pharmaceuticals Ltd Return on Equity should also monitor related metrics such as P/E, P/B, EV/EBITDA, D/E, and ROE to get a complete fundamental picture.

Regular tracking of Akums Drugs & Pharmaceuticals Ltd Return on Equity helps investors make informed decisions based on long-term growth, valuation trends, and financial performance.